000 04344nam a22003855i 4500
001 305995
003 MX-SnUAN
005 20160429160014.0
007 cr nn 008mamaa
008 150903s2012 gw | o |||| 0|eng d
020 _a9783642287114
_99783642287114
024 7 _a10.1007/9783642287114
_2doi
035 _avtls000358840
039 9 _a201509031017
_bVLOAD
_c201405070237
_dVLOAD
_y201402191541
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC321-580
100 1 _aCarter, Cameron S.
_eeditor.
_9345148
245 1 0 _aBrain Imaging in Behavioral Neuroscience /
_cedited by Cameron S. Carter, Jeffrey W. Dalley.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2012.
300 _ax, 391 páginas 47 ilustraciones, 42 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aCurrent Topics in Behavioral Neurosciences,
_x1866-3370 ;
_v11
500 _aSpringer eBooks
505 0 _aFrom the contents -- Preface -- Food and drug reward: overlapping circuits in human obesity and addiction -- Nonhuman Primate Models of Addiction and PET Imaging: Dopamine System Dysregulation -- Neural and behavioral endophenotypes in ADHD -- Experimental protocols for behavioral imaging: Seeing animal models of drug abuse in a new light -- Molecular Imaging and the Neuropathologies of Parkinson’s disease -- Imaging of Seasonal Affective Disorder and Seasonality effects on serotonin and dopamine function in the Human Brain -- Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain -- MR Spectroscopic Studies of the Brain in Psychiatric Disorders -- fMRI As A Measure of Cognition Related Brain Circuitry In Schizophrenia -- MRI studies in Late-Life Mood Disorders -- The role of diffusion tensor imaging in the study of cognitive aging -- Structural, functional and spectroscopic MRI studies of Methamphetamine addiction -- Pharmacological MRI Approaches to Understanding Mechanisms of Drug Action.
520 _aThis volume highlights the remarkable new developments in brain imaging, including those that apply magnetic resonance imaging (MRI) and Positron Emission Tomography (PET), that allow us to non invasively study the living human brain in health and in disease.  These technological advances have allowed us to obtain new and powerful insights into the structure and function of the healthy brain as it develops across the life cycle, as well as the molecular make up of brain systems and circuits as they develop and change with age.  New brain imaging technologies have also given us new insights into the causes of many common brain disorders, including ADHD, schizophrenia, depression and Alzheimer’s disease, which collectively affect a large segment of the population.  These new insights have major implications for understanding and treating these brain disorders, and are providing clinicians with the first ever set of biomarkers that can be used to guide diagnosis and monitor treatment effects. The advances in brain imaging over the last 20 years, summarized in this volume, represent a major advance in modern biomedical sciences.   The Authors of this volume are leaders in the development of PET and MRI methods as well as clinical and translational researchers skilled in their use in patients with brain disorders. Individual chapters of this volume focus on the use of specific methodologies, covering the full range of PET chemistry based approaches as well as MRI methods from structural and diffusion tensor based imaging, to functional MRI of functional brain circuitry, to pharmacological MRI and MRI spectroscopic molecular imaging. 
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aDalley, Jeffrey W.
_eeditor.
_9345149
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783642287107
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-642-28711-4
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c305995
_d305995